Literature DB >> 21324935

Cardiac resynchronization therapy: from treatment to prevention.

Christophe Leclercq, Jagmeet P Singh.   

Abstract

Mesh:

Year:  2011        PMID: 21324935     DOI: 10.1093/eurheartj/ehr016

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

Review 1.  Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanisms.

Authors:  Hana Cho; Andreas S Barth; Gordon F Tomaselli
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-01

2.  Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue.

Authors:  Justus Stenzig; Marc D Lemoine; Aaltje M S Stoter; Kinga M Wrona; Marta Lemme; Wesam Mulla; Yoram Etzion; Thomas Eschenhagen; Marc N Hirt
Journal:  J Mol Cell Cardiol       Date:  2021-10-08       Impact factor: 5.000

3.  Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.

Authors:  Yanmei Chen; Chongyang Duan; Feng Liu; Shuxin Shen; Pingyan Chen; Jianping Bin
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

4.  Speckle-tracking echocardiography elucidates the effect of pacing site on left ventricular synchronization in the normal and infarcted rat myocardium.

Authors:  Michal Mor; Wesam Mulla; Sigal Elyagon; Hovav Gabay; Shani Dror; Yoram Etzion; Noah Liel-Cohen
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

5.  Prominent differences in left ventricular performance and myocardial properties between right ventricular and left ventricular-based pacing modes in rats.

Authors:  Wesam Mulla; Sharon Etzion; Sigal Elyagon; Roni Gillis; Michael Murninkas; Yuval Konstantino; Ingra Mannhardt; Thomas Eschenhagen; Noah Liel-Cohen; Yoram Etzion
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.